SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 Update

SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 Update

Dr. Per Karlsson | San Antonio Breast Cancer Symposium 2022 | General SessionПодробнее

Dr. Per Karlsson | San Antonio Breast Cancer Symposium 2022 | General Session

Can we forego axillary lymph node dissection in early breast cancer?Подробнее

Can we forego axillary lymph node dissection in early breast cancer?

SABCS Snippets: KEYNOTE-522 Phase 3 ResultsПодробнее

SABCS Snippets: KEYNOTE-522 Phase 3 Results

SABCS Snippets: Results of NRG Oncology/NSABP-51/RTOG 1304Подробнее

SABCS Snippets: Results of NRG Oncology/NSABP-51/RTOG 1304

NSABP B-51: Can we forego radiation in early breast cancer? | #cancer #oncologyПодробнее

NSABP B-51: Can we forego radiation in early breast cancer? | #cancer #oncology

Update on Keynote 522, the current standard of care for triple negative breast cancer.Подробнее

Update on Keynote 522, the current standard of care for triple negative breast cancer.

SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02Подробнее

SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02

Highlights from SABCS 2023: recognition for breast cancer preventionПодробнее

Highlights from SABCS 2023: recognition for breast cancer prevention

SABCS 2022 highlightsПодробнее

SABCS 2022 highlights

SABCS 2022: DESTINY-Breast02 + DESTINY-Breast03Подробнее

SABCS 2022: DESTINY-Breast02 + DESTINY-Breast03

SABCS 2022 takeawaysПодробнее

SABCS 2022 takeaways

Highlights from SABCS 2023Подробнее

Highlights from SABCS 2023

Breast Cancer Breakthroughs Episode 6: Highlights from SABCS 2023Подробнее

Breast Cancer Breakthroughs Episode 6: Highlights from SABCS 2023

SABCS 2023 Breast Cancer Highlights – NATALEE, MONARCH-3, INAVO120, TROPION-Breast01Подробнее

SABCS 2023 Breast Cancer Highlights – NATALEE, MONARCH-3, INAVO120, TROPION-Breast01